There is an exciting shift happening in dentistry.
For years, periodontal therapy has centered around one primary goal: remove biofilm and calculus as thoroughly as possible. While that foundation will never change, we now have additional tools that can help us manage one of the biggest drivers of disease—bacteria.
One of those tools is iodine.
Whether you are hearing more about povidone-iodine (PVP-I) or newer molecular iodine products, it’s worth understanding where they fit into today’s evidence-based periodontal therapy.
Notice I said fit.
They are not miracle products.
They are not replacements for excellent instrumentation.
They are not shortcuts.
They are adjuncts.
And when used appropriately, adjuncts can help improve clinical outcomes for the right patients.
The Future of Periodontal Therapy Is Microbial Management
Periodontal disease is an inflammatory disease driven by bacterial biofilm.
If bacteria initiate the disease process, then reducing the bacterial burden should always be part of our treatment strategy.
Mechanical debridement remains the gold standard.
However, we also know that some patients continue to struggle despite excellent care. Others have recurring inflammation, high caries risk, xerostomia, orthodontic appliances, limited dexterity, or medical conditions that make plaque control more difficult.
These are the patients who may benefit from additional antimicrobial support.
That’s where iodine enters the conversation.
Why Iodine?
Iodine has actually been used safely in medicine for decades.
Today, both povidone-iodine and molecular iodine are receiving renewed attention because they provide broad antimicrobial activity against bacteria, viruses, and fungi while remaining relatively inexpensive and easy to incorporate into clinical care.
Potential applications include:
- Preprocedural rinses
- Adjunctive periodontal therapy
- Caries management
- Home-care support
- Patients with persistent inflammation
- High bacterial burden
- Patients who have not responded well to previous therapy
For the right patient, reducing the microbial challenge gives tissues a better opportunity to heal after mechanical therapy.
Povidone-Iodine vs. Molecular Iodine
Although both deliver iodine, they are different products.
Povidone-Iodine (PVP-I) uses a carrier that slowly releases iodine. It has a long history of medical use and has demonstrated benefits as an adjunct during periodontal therapy and caries management.
Molecular iodine is a newer technology that delivers free iodine without the carrier. It works rapidly, is clear, non-staining, and offers very short application times, making it attractive for patient home care and tray delivery systems.
Understanding these differences allows clinicians to select the appropriate product for the appropriate clinical situation.
One of the Biggest Myths We Need to Stop Repeating
One misconception continues to circulate in dentistry:
“If someone has a shellfish allergy, they can’t have iodine.”
Current evidence tells us this simply isn’t true.
Shellfish allergies are reactions to proteins found in shellfish, not iodine itself.
Of course, every patient’s medical history deserves careful review. Patients with advanced thyroid disease, pregnancy, breastfeeding, certain medical conditions, or known product sensitivities require additional consideration before recommending iodine-based products.
As with every treatment recommendation, patient selection matters.
The Real Secret Isn’t the Product, It’s The Diagnosis
No antimicrobial can compensate for an inaccurate diagnosis.
If inflammation is present alongside attachment loss and bone loss, we are managing periodontal disease—not simply gingivitis.
When we diagnose correctly, perform meticulous mechanical therapy, educate patients, and selectively incorporate evidence-based adjuncts when appropriate, we dramatically improve our opportunity for successful outcomes.
Technology doesn’t replace clinical skills and judgment.
It supports it.
Five Questions to Ask Yourself Tomorrow
As you return to practice, challenge yourself with these questions:
- Am I accurately identifying patients who have active periodontal disease?
- Which patients continue to experience inflammation despite quality care?
- Do I have patients with high bacterial burden or elevated caries risk who may benefit from adjunctive antimicrobial therapy?
- Have I reviewed my medical history screening to identify contraindications before recommending iodine products?
- Does my team have a standardized protocol for when adjunctive therapies should and should not be used?
These conversations elevate our profession from simply cleaning teeth to truly managing disease.
The Bottom Line
Modern dental hygiene is no longer just about removing deposits.
It is about understanding the oral microbiome, reducing inflammation, managing disease, and helping patients achieve healthier outcomes through evidence-based care.
Iodine isn’t the answer for every patient.
But when combined with accurate diagnosis, exceptional instrumentation, patient education, and individualized treatment planning, it may become another valuable tool in helping our patients heal.
The future of periodontal therapy isn’t about replacing what already works.
It’s about thoughtfully adding the right tools at the right time for the right patient.
That is what modern dental hygiene looks like.